Literature DB >> 31971602

Psoriasis and Co-morbidity.

Mina Amin1, Erica B Lee, Tsen-Fang Tsai, Jashin J Wu.   

Abstract

Psoriasis is associated with multiple co-morbid medical conditions. The purpose of this study is to evaluate the relationships between psoriasis and cardiovascular disease, psoriatic arthritis, mental health conditions, and immune-mediated diseases, respectively. A literature search was performed during the study period January 1, 2015 to December 18, 2018. Of 2,499 records identified, 28 met our criteria selection and were included in this review. The relationships between psoriasis and these multiple comorbid disease conditions are discussed and are important to consider when developing the treatment plan and overall management of patients with psoriasis. Early recognition and treatment of comorbid disease conditions is important to help improve the quality of life for these patients.

Entities:  

Keywords:  cardiovascular disease; depression; immune-mediated disease; mental health conditions; psoriasis; psoriatic arthritis

Mesh:

Substances:

Year:  2020        PMID: 31971602      PMCID: PMC9128942          DOI: 10.2340/00015555-3387

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  47 in total

1.  Choosing First-Line Biologic Treatment for Moderate-to-Severe Psoriasis: What Does the Evidence Say?

Authors:  Mina Amin; Daniel J No; Alexander Egeberg; Jashin J Wu
Journal:  Am J Clin Dermatol       Date:  2018-02       Impact factor: 7.403

2.  Evidence for the association of Hashimoto's thyroiditis with psoriasis: a cross-sectional retrospective study.

Authors:  Tina Kiguradze; Finola M Bruins; Nicholas Guido; Tanya Bhattacharya; Alfred Rademaker; Aleksandra G Florek; Alba Posligua; Shatil Amin; Anne E Laumann; Dennis P West; Beatrice Nardone
Journal:  Int J Dermatol       Date:  2017-02-19       Impact factor: 2.736

3.  Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.

Authors:  Jashin J Wu; Christopher G Rowan; Judith D Bebchuk; Mary S Anthony
Journal:  J Am Acad Dermatol       Date:  2015-03-05       Impact factor: 11.527

4.  Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.

Authors:  Bruce Kirkham; Kurt de Vlam; Wenzhi Li; Robert Boggs; Lotus Mallbris; Henk W Nab; Miriam Tarallo
Journal:  Clin Exp Rheumatol       Date:  2014-12-22       Impact factor: 4.473

Review 5.  Unraveling Vascular Inflammation: From Immunology to Imaging.

Authors:  Heather L Teague; Mark A Ahlman; Abass Alavi; Denisa D Wagner; Andrew H Lichtman; Matthias Nahrendorf; Filip K Swirski; Frank Nestle; Joel M Gelfand; Mariana J Kaplan; Steven Grinspoon; Paul M Ridker; David E Newby; Ahmed Tawakol; Zahi A Fayad; Nehal N Mehta
Journal:  J Am Coll Cardiol       Date:  2017-09-12       Impact factor: 24.094

6.  Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis.

Authors:  Alexander Egeberg; Louise E Bruun; Lotus Mallbris; Gunnar H Gislason; Lone Skov; Jashin J Wu; Peter R Hansen
Journal:  J Am Acad Dermatol       Date:  2016-06-07       Impact factor: 11.527

7.  Self-reported depression in psoriasis is associated with subclinical vascular diseases.

Authors:  Tsion M Aberra; Aditya A Joshi; Joseph B Lerman; Justin A Rodante; Asha K Dahiya; Heather L Teague; Qimin Ng; Joanna I Silverman; Alexander V Sorokin; Taufiq Salahuddin; Benjamin N Lockshin; Mark A Ahlman; Martin P Playford; Marcus Y Chen; Joel M Gelfand; Nehal N Mehta
Journal:  Atherosclerosis       Date:  2016-05-27       Impact factor: 5.162

Review 8.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

9.  Ustekinumab Treatment and Improvement of Physical Function and Health-Related Quality of Life in Patients With Psoriatic Arthritis.

Authors:  Proton Rahman; Lluis Puig; Alice B Gottlieb; Arthur Kavanaugh; Iain B McInnes; Christopher Ritchlin; Shu Li; Yuhua Wang; Michael Song; Alan Mendelsohn; Chenglong Han
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-10-21       Impact factor: 4.794

Review 10.  Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.

Authors:  Jörg Christoph Prinz
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

View more
  12 in total

Review 1.  Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management.

Authors:  Eveline De Brandt; Tom Hillary
Journal:  Psoriasis (Auckl)       Date:  2022-05-25

2.  Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease.

Authors:  Paolo Gisondi; Davide Geat; Martina Maurelli; Luca Degli Esposti; Francesco Bellinato; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2022-04-20

3.  The Diagnostic-Therapeutic Care Pathway in Psoriasis: Towards ISO 9001:2015 Certification.

Authors:  Federica Veronese; Francesca Graziola; Edoardo Cammarata; Marco Andreassi; Vanessa Mazzoletti; Camilla Taglietti; Gaia Navarra; Paola Savoia; Rossana Tiberio
Journal:  Medicina (Kaunas)       Date:  2020-05-22       Impact factor: 2.430

Review 4.  Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities.

Authors:  Chandra L Kakarala; Mohammad Hassan; Rishab Belavadi; Sri Vallabh Reddy Gudigopuram; Ciri C Raguthu; Harini Gajjela; Iljena Kela; Ibrahim Sange
Journal:  Cureus       Date:  2021-11-17

5.  Comparison of the risk of heart failure in psoriasis patients using anti-TNF α inhibitors and ustekinumab.

Authors:  Ju Hee Han; Hae Eun Park; Yeong Ho Kim; Jin-Hyung Jung; Ji Hyun Lee; Young Min Park; Chul Hwan Bang
Journal:  ESC Heart Fail       Date:  2022-02-17

Review 6.  Oxidative Stress Induced by High Salt Diet-Possible Implications for Development and Clinical Manifestation of Cutaneous Inflammation and Endothelial Dysfunction in Psoriasis vulgaris.

Authors:  Ivana Krajina; Ana Stupin; Marija Šola; Martina Mihalj
Journal:  Antioxidants (Basel)       Date:  2022-06-27

7.  Management of a Chronic Skin Disease in Primary Care: An Analysis of Early-Career General Practitioners' Consultations Involving Psoriasis.

Authors:  Sameerah Nawaz; Amanda Tapley; Andrew R Davey; Mieke L van Driel; Alison Fielding; Elizabeth G Holliday; Jean Ball; Irena Patsan; Alyse Berrigan; Simon Morgan; Neil A Spike; Kristen FitzGerald; Parker Magin
Journal:  Dermatol Pract Concept       Date:  2021-05-20

Review 8.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837

9.  Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis.

Authors:  Martin Bauer; Edith Lackner; Peter Matzneller; Valentin Al Jalali; Sahra Pajenda; Vincent Ling; Christof Böhler; Werner Braun; Reinhard Braun; Maximilian Boesch; Patrick M Brunner; Markus Zeitlinger
Journal:  Front Med (Lausanne)       Date:  2021-07-16

10.  Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation.

Authors:  Dennis Niebel; Dagmar Wilsmann-Theis; Thomas Bieber; Mark Berneburg; Joerg Wenzel; Christine Braegelmann
Journal:  Dermatopathology (Basel)       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.